CCL2 and infection: At T1, 2 months post-infection, the LM17- and LJL143-immunized dogs presented higher levels of IFN-γ, IL-6, IL-18, CXCL10, GM-CSF, IL-7, IL-15, and CCL2 in comparison to controls.